Skip to main content

Table 1 Relationship between ACSL4 and clinicopathological characteristics in CHOL patients

From: ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

 

ACSL4 expression

 

Variable

High(N = 33)

Low(N = 33)

p value

Sex

  

0.6144

 Male

19

21

 

 Female

14

12

 

Age

  

0.4594

 < 65

17

14

 

 ≥ 65

16

19

 

TNM stage

  

0.1593

 I-II

22

27

 

 III-IV

11

6

 

Status

  

0.0797

 Death

23

16

 

 Alive

10

17

 

CA19-9,IU/L

90.98 (1.2, 616.2)

667.4 (1.0, 6910.0)

0.0694